Select Committee on Public Accounts Minutes of Evidence


Examination of Witnesses (Questions 20 - 39)

WEDNESDAY 16 NOVEMBER 2005

DEPARTMENT OF HEALTH AND NORFOLK AND NORWICH UNIVERSITY HOSPITAL

  Q20  Chairman: That still does not really say a great deal. You may want to send us a note on that[1]; we would like to have some evidence behind that. Basically you are saying that this £130 million that the shareholders have withdrawn from this project is going to be recycled into other hospitals, are you?

  Mr Coates: I said a proportion.

  Q21  Chairman: That was the implication of your question but I would like to have more evidence behind that because I would be surprised if that were entirely true. I do not know, but I would be surprised if it was. If you look at page 16, paragraph 2.1, it says there, "There are a range of factors, some of which have yet to be fully analysed by the Department, which will have affected the pricing of current PFI hospital deals." So how can you, Mr Coates, judge whether these deals are good value if you cannot explain all the reasons why the contract prices have changed over time?

  Mr Coates: The Department of Health finance team do keep a close watch on the PFI market through a variety of sources. We collect construction and service price trends from the NHS; we have copies of every financial model of every PFI transaction in the NHS; and we also collect data from the Treasury across departmental issues in terms of prices and such like. We believe we do keep a fairly close watch on what the PFI markets do in terms of price and activity.

  Q22  Chairman: Let us look at page 14, paragraph 1.5, "After sharing in refinancing benefits NHS Trusts will continue to pay a premium on the financing costs on early PFI hospital deals." So is this kind of refinancing and this deal entirely fair on the NHS Trust who entered into early PFI deals, because they have to bear the higher financing costs?

  Mr Coates: Indeed, and I think the Report does go on to say elsewhere that we have to look at other costs that the Trust may have incurred if it had come later in the process. It seems to me that there are two issues for the Department. One is: is the Trust paying more than it should for this hospital? And: is the Trust paying more than others are paying for this hospital? We have undertaken further work in the Department looking at the various factors and it is not easy to bring forward today's cost, but we believe that the additional construction costs and the costs that the Trust would have incurred if it built the hospital today do balance off against it.

  Q23  Chairman: My last question to you, Mr Coates, just speaking on behalf of the taxpayer—you are the guardian of the taxpayer on this—are you entirely happy with a situation where private investors have got away with a rate of return of 60%? Does that seem to you a good deal for us?

  Mr Coates: It is hard to defend such large returns, but all I can say is that the contract itself gave us no right of access and the private sector has done a deal with the taxpayer generally to share those benefits with us on a post hoc basis.

  Chairman: I am sure my colleagues can come back on that. Mr Bacon.

  Q24  Mr Bacon: Chairman, thank you very much. I would like to start with the question about the building costs because the NAO Report says on page 4 that additional building costs arising from construction inflation, if you had done it later, probably offset the benefits of lower financing costs that you would get if you were doing it now, and therefore that is all right then, so to speak. Is it not the case, Mr Forden, that at the end of the day nobody trying to let this contract on behalf of your Trust was in a position to know what would happen to construction costs going forward; is that correct?

  Mr Forden: That is correct.

  Q25  Chairman: Is it not also true that you are basically faced with a premium compared with other PFI deals, even after your refinancing?

  Mr Forden: The audit Report says there is a premium that we pay after the refinancing. If you took the same financing terms as we could expect today, if we were able to achieve those when we let the contract and financial close in 1998.

  Q26  Mr Bacon: Mrs Dugdale, could you say something about the way the financing was approached because there was no competition for the financing, was there?

  Mrs Dugdale: Initially, no. When the initial deal was made there was not a competition.

  Q27  Mr Bacon: Why not?

  Mrs Dugdale: Because there was a two-year gap between commercial close and financial close, but even during that period the PFI market for health was very new. There were discussions with the PFI partners about the possibility of a competition, but it was determined that there was not enough of the market to actually have a competition at that stage.

  Q28  Mr Bacon: How does one determine that other than by asking?

  Mrs Dugdale: It was agreed between us that there was not enough of a market at that stage, and if you look at PFI deals closing at around the same time there was no competition because funding competitions were not known.

  Q29  Mr Bacon: Mr Finlay, is it not correct that Octagon had a competition when it closed the deal for its refinancing—it had a funding competition?

  Mr Finlay: At the time that Octagon carried out its refinancing, yes, it held a funding competition, and that is referred to in figure 23 in our Report.

  Q30  Mr Bacon: Mr Glicksman, when the Treasury building, which was a PFI project, wanted to finance it had a competition, did it not?

  Mr Glicksman: It did, but I think that was the very first one that we had done in the public sector, and it followed a gap when the project contract had been put on hold for a couple of years, and we picked it up again.

  Chairman: We will have to break for about five minutes.

The Committee suspended from 15.52 pm to 15.58 pm for a division in the House

  Q31  Mr Bacon: I was asking about competitions and Mr Glicksman had agreed that the Treasury building had a competition for its financing, although it was the first one, he said, and Mr Finlay agreed that Octagon had had a competition for its financing. When most people go out into the market place looking for a mortgage to buy a house they do not necessarily go to the first building society that gives them the price, do they?

  Mrs Dugdale: No, but I think that you have to appreciate that we were the groundbreaker for the market for PFI financing, and at the time when the original deal was struck there was not such a thing as a funding competition.

  Q32  Mr Bacon: There was not such a thing as a PFI bond market. You say that there was not such a thing as a funding competition and I find that is not possible to believe. For PFI per se maybe, because PFI was new, but 20 years ago when I left university and started working in an investment bank we did what were commonly known as "beauty parades"; they are a standard feature of the City, a standard feature of how things work. You go along with three or four other banks, you tout your stuff, you strut your stuff, you tout you wares and then the client chooses. Is that not obvious, and why was that not done?

  Mr Coates: Can I come in there?

  Q33  Mr Bacon: Actually I was asking Mrs Dugdale. Was that not an obvious thing to do?

  Mrs Dugdale: In the PFI market at the time, funding competitions did not take place in the market, they were not something that were done ordinarily in the market. Also, PFI at the time was very much the concept of a package, so that the private sector brought a package deal to the public sector, which included the finance as part of that overall package.

  Q34  Mr Bacon: I will not pursue that any further. Can I ask you to turn to page 12? The hospital, I think I am right in saying, is now paying £1.7 million per year less in the annual unitary charge than would otherwise have been the case before the refinancing; is that right? That is basically how you are taking your gains?

  Mr Forden: It is paying a total of £3.6 million a year less—

  Q35  Mr Bacon: Is it?

  Mr Forden: Of which £1.8 million was due to the refinancing gain and £1.8 million was as a result of extending the contract period.

  Q36  Mr Bacon: I am talking specifically in relation to the refinancing gain, it was £1.7 million?

  Mr Forden: Yes.

  Q37  Mr Bacon: And it is true that, as the Chairman said at the beginning, you have taken on additional potential termination liabilities because of the refinancing?

  Mr Forden: We have not taken on additional termination liability unless we terminate the contract ourselves, sorry.

  Q38  Mr Bacon: Termination liability will only kick in if there was termination, I would have thought that was self-evident. The point I am referring to is maximum increase in termination liabilities in figure 12, £257 million. Obviously it is a contingent liability, if you like, a contingent situation, but it seems to me that in return for getting this extra refinancing gain that you shared, which means you pay £1.7 million per year less, you have taken on the risk—the risk, mark you—of £257 million extra should, for any reason, Octagon fail. That is correct, is it not?

  Mr Forden: Should we wish to withdraw from the contract—

  Q39  Mr Bacon: If Octagon fail—

  Mr Forden: No, if Octagon fail actually we have not taken on that liability, no, because what happens then is we become responsible for servicing the debt, which is true.


1   Ev 17 Back


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2006
Prepared 3 May 2006